Contact
searchSearch
HMP Global
Practice Management

HealthJobConnect Aims to Simplify Your Healthcare Recruitment

Amanda Balbi, Associate Director
10/10/2023

HealthJobConnect is a digital job board where healthcare providers can list their openings for 30, 60, or 90 days and find the right healthcare candidate quickly and efficiently. Job listings appear across the HMP Global Learning Network, with an audience of more than 1 million healthcare providers nationwide. Job posters can connect with the best talent in the healthcare industry, simplifying their healthcare recruitment process. 

For job seekers, it's easy to advance their careers through the simplified application process. Their future career starts with HealthJobConnect.

Read more about the job board and get started here: https://www.healthjobconnect.com/.

Popular Articles

Dr Amit Garg: Comorbidity Screening in HS
Q&As
Dr Amit Garg: Comorbidity Screening in HS
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist
News
Baricitinib is Safe and Effective for the Treatment of Alopecia Areata in Adult Patients
06/24/2021
In adult patients with alopecia areata and at least 50% scalp hair loss, the oral JAK inhibitor baricitinib is a safe and effective treatment option.
In adult patients with alopecia areata and at least 50% scalp hair loss, the oral JAK inhibitor baricitinib is a safe and effective treatment option.
In adult patients with alopecia...
06/24/2021
The Dermatologist
John’s Story PsO Patient Testimonial: A Missed Conversation
SPONSORED
John’s Story PsO Patient Testimonial: A Missed Conversation
04/04/2022
John, a patient with psoriatic disease, describes the importance of early screening for psoriatic arthritis in people with plaque psoriasis.
John, a patient with psoriatic disease, describes the importance of early screening for psoriatic arthritis in people with plaque psoriasis.
John, a patient with psoriatic...
04/04/2022
Dermatology
lawrence green MD
Podcasts
The Future of Sun Protection, Inclusivity in Dermatology, and the Impact of the Environment on Skin
03/27/2022
During AAD 2022, The Dermatologist met with Lawrence Green, MD, who reviewed the future of sun protection for patients, how the AAD is working to expand inclusivity in the field of dermatology, and finally reviewed the impact the environment...
During AAD 2022, The Dermatologist met with Lawrence Green, MD, who reviewed the future of sun protection for patients, how the AAD is working to expand inclusivity in the field of dermatology, and finally reviewed the impact the environment...
During AAD 2022, The...
03/27/2022
The Dermatologist
News
Intermediate Filament Cytoskeleton and PPAR Signaling Pathway Key Regulators of Psoriasis Lesions
10/22/2022
Researchers aimed to determine the factors present in psoriatic lesions by providing a comprehensive mRNA profile of patients with psoriasis.
Researchers aimed to determine the factors present in psoriatic lesions by providing a comprehensive mRNA profile of patients with psoriasis.
Researchers aimed to determine...
10/22/2022
Dermatology

Sign Up for eNews!

Dermatology Newsletter

Dermatology News

psoriasis
News
Apremilast for Pediatric Patients With Moderate To Severe Plaque Psoriasis
09/11/2024
Researchers aimed to evaluate the efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis.
Researchers aimed to evaluate the efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis.
Researchers aimed to evaluate...
09/11/2024
Dermatology
psoriasis
News
Baseline Score on the Validated Psoriasis Symptoms and Signs Diary
08/22/2024
Researchers aimed to establish meaningful within-patient score change thresholds on the Psoriasis Symptoms and Signs Diary.
Researchers aimed to establish meaningful within-patient score change thresholds on the Psoriasis Symptoms and Signs Diary.
Researchers aimed to establish...
08/22/2024
Dermatology
psoriasis
News
Apremilast for Patients with Moderate to Severe Genital Psoriasis
08/09/2024
Researchers aimed to evaluate the efficacy and safety of apremilast 30 mg twice daily in patients with genital psoriasis.
Researchers aimed to evaluate the efficacy and safety of apremilast 30 mg twice daily in patients with genital psoriasis.
Researchers aimed to evaluate...
08/09/2024
Dermatology
psoriasis
News
Dermoscopy in Psoriasis: Clinical Value
07/24/2024
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained...
07/24/2024
Dermatology
psoriasis
News
Psoriasis as a Systemic Disease: Evidence and Management
07/09/2024
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the...
07/09/2024
Dermatology
psoriasis
News
Cardiovascular Risk Assessment in Psoriasis
06/20/2024
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate...
06/20/2024
Dermatology
psoriasis
News
Nail Psoriasis Association With IL-17
06/07/2024
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate...
06/07/2024
Dermatology
psoriasis
News
Bibliometric Analysis of Metabolomics Trends in Psoriasis
05/13/2024
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a...
05/13/2024
Dermatology
psoriasis
News
Determining the Risk Factors for Joint Damage in Psoriasis
05/01/2024
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the...
05/01/2024
Dermatology
psoriasis
News
CD6-ALCAM Polymorphisms Potentially Modulate Psoriasis Risk and Outcomes
04/24/2024
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate...
04/24/2024
Dermatology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use